Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2010
10/07/2010US20100256378 Fluorescent cellular markers
10/07/2010US20100256369 Quorum sensing inhibitor
10/07/2010US20100256365 Compounds and methods for kinase modulation, and indications therefor
10/07/2010US20100256356 Heterobicyclic pyrazole compounds and methods of use
10/07/2010US20100256181 Non-nucleoside reverse transcriptase inhibitors
10/07/2010US20100256177 Flavopereirine derivatives for cancer therapy
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256139 Anti-Viral Compounds
10/07/2010US20100256135 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
10/07/2010US20100256133 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
10/07/2010US20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010US20100254916 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
10/07/2010DE112008002449T5 Organische Elektrolumineszenzanordnung Organic electroluminescence
10/07/2010CA2757415A1 Autotaxin inhibitors
10/07/2010CA2756815A1 Peri-fused pyrazolo-pyrimidine compounds
10/07/2010CA2756810A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
10/07/2010CA2756809A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
10/07/2010CA2756807A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
10/07/2010CA2755132A1 Indolizine derivative and use thereof for medical purposes
10/07/2010CA2738573A1 Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
10/06/2010EP2236511A2 Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof
10/06/2010EP2235017A1 Spiroindolinone derivatives as anticancer agents
10/06/2010EP2235016A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235015A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2235013A1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
10/06/2010EP2235012A2 4-aminopyrimidine derivatives as histamine h4 receptor antagosnists
10/06/2010EP2235011A1 Substituted pyrrolo[2, 3-b]and pyrazolo[3, 4-b]pyridines for use as adenosine receptor ligands
10/06/2010EP2235010A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
10/06/2010EP2235009A1 Synthesis of paliperidone
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2234997A1 Process for the preparation of pyrido ý2,1-a¨isoquinoline derivatives
10/06/2010EP2234980A1 Fused cynopryridines and the use thereof
10/06/2010EP2234968A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/06/2010EP2234485A1 Stable laquinimod preparations
10/06/2010EP1996590B1 Spiroindolinone derivatives
10/06/2010EP1725555B1 Pyrrolopyridine-2-carboxylic acid hydrazides as inhibitors of glycogen phosphorylase
10/06/2010EP1633752B1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010EP1272492B1 Method for producing triethylene diamine, using ethylene diamine
10/06/2010CN1629162B Unidimensional linear bieuropium(III) monohydrate and its preparation method
10/06/2010CN101855223A Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
10/06/2010CN101855222A Imidazol (1,2-A)pyridines and related compounds with activity at cannabinoid CB2 receptors
10/06/2010CN101855218A Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
10/06/2010CN101851237A spiro compounds, method for preparing same and application thereof
10/06/2010CN101851236A Preparations of new polymorphic forms of varenicline tartrate
10/06/2010CN101851235A Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/06/2010CN101851234A Pyrrolequinoline quinone lithium salt derivative and preparation method thereof
10/06/2010CN101851216A Oxadiazole derivative, and electronic device, and lighting device using oxadiazole derivative
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807994 comprising N,N'-diaryl-substituted-1,4,5,8-naphthalene tetracarboxylic acid diimide compound; integrated circuits; solar cells
10/05/2010US7807836 Dimerizing a naphthalene-1,8-dicarboximide, reoxidation of the resulting perylene-3,4:9,10-tetracarboxylic diimide, hydrolyzing the diimide to the tetraalkali metal salt of perylene-3,4:9,10-tetracarboxylic acid, convert it into perylene-3,4:9,10-tetracarboxylic dianhydride
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807687 Reaction of a 2,4-disubstituted quinolinone with an aldehyde in the presence of a base to prepare a benzylidene hydroquinolinone, reaction of product with benzamidinium hydrochloride under basic conditions to prepare a 1,4,5,6-tetrahydropyrido[3,2-h]quinazoline, oxidation; performance efficiency; OLED
10/05/2010US7807684 HIV reverse transcriptase inhibitors
10/05/2010US7807676 1-(4-fluoro-7-(3-methyl-1H-pyrazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS; immunomodulators; with AIDS antiviral, antiinfective agent, HIV entry inhibitor
10/05/2010US7807673 protein tyrosine kinase inhibitors such as N-[3-(3-{2-[(2-Methyl-1,2,3,4-tetrahydro-7-isoquinolinyl)amino]-4-pyrimidinyl}pyrazolo[1,5-a]pyridin-2-yl)phenyl]-2-(2-thienyl)acetamide, used for treating breast cancer in a human; anticarcinogenic agents
10/05/2010US7807671 viricides such as 1-(7-bromo-4-fluoro-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione , used for the treatment of HIV and AIDS
10/05/2010US7807667 4-(5-Benzo[1,3]dioxol-5-yl-[1,3,4]oxadiazol-2-yl)-1,4-diaza-bicyclo[3.2.2]-nonane or fumaric acid salt; diseases or disorders related to smooth muscle contraction, endocrine diseases, neurodegenerative disorders, inflammation, pain, and withdrawal symptoms caused by the termination of substance abuse
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
10/05/2010CA2362930C Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111527A1 Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
09/30/2010WO2010111460A1 Inhibitors of nf-kb
09/30/2010WO2010111418A2 Process for the production of fused, tricyclic sulfonamides
09/30/2010WO2010110414A1 Indazolepropionic acid amide compound
09/30/2010WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109386A1 Method for the industrial purification of biologically active phycotoxins
09/30/2010WO2010109084A2 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
09/30/2010WO2010108995A1 Dinitroxide biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108584A1 Synthesis of n-substituted furan-2(5h)-ones
09/30/2010WO2010108268A1 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010WO2010075376A3 Anti-viral compounds
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010US20100249419 Utilization of novel compounds with amyloid affinity and method of producing the same
09/30/2010US20100249418 Novel compound having affinity for amyloid
09/30/2010US20100249414 Crystalline form ii of 7-(dimethoxy-methyl) camptothecin, its use as intermediate and products obtained therefrom
09/30/2010US20100249408 Use of novel compound having affinity for amyloid, and process for production of the same
09/30/2010US20100249407 Novel Compound Having Affinity to Amyloid
09/30/2010US20100249386 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249176 Heterocycle amide t-type calcium channel antagonists
09/30/2010US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100249120 Substituted pyrazolo-pyrrolo-pyridine-dione compounds
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249114 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 646